Development of new vaccines and diagnostic reagents against tuberculosis

被引:92
作者
Mustafa, AS [1 ]
机构
[1] Kuwait Univ, Fac Med, Dept Microbiol, Safat 13110, Kuwait
关键词
tuberculosis; diagnosis; vaccine; genome sequence; regions deleted;
D O I
10.1016/S0161-5890(02)00048-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tuberculosis (TB) is a major infectious disease problem with one-third of the world population infected, 8 million people developing the active disease and 2 million dying of TB each year. The attenuated Mycobacterium bovis Bacillus Calmette Guerin (BCG) is the only available vaccine against TB. However, the trials conducted in different parts of the world have shown that this vaccine doe not provide consistent protection against TB. The purified protein derivative (PPD) of Mycobacterium tuberculosis is the commonly used reagent for the diagnosis of TB. However, PPD lacks specificity because of the presence of antigens crossreactive with M. bovis BCG and other mycobacteria. The studies to identify M. tuberculosis antigens and epitopes as candidates for new protective vaccines and specific diagnostic reagents against TB have led to the identification and characterization of several major antigens of M. tuberculosis including heat shock proteins (hsp) and secreted antigens present in the culture filtrate (CF) of M. tuberculosis. Some of these antigens have shown promise as new candidate vaccines (hsp60, Ag85 and ESAT-6, etc.) and specific diagnostic reagents (ESAT-6 and CFP10, etc.) for TB. Moreover, in the mouse model of TB, vaccination with DNA-hsp60 has immunotheraputic effects and helps in eradication of persisters. In addition, identification of proper adjuvant and delivery systems has shown the promise to overcome the problem of poor immunogenicity associated with subunit and peptide based vaccines. More recently, the comparison of the genome sequence of M. tuberculosis with M. bovis BCG and other mycobacteria has led to the identification of M. tuberculosis-specific genomic regions. Evaluation of these regions for encoding proteins with immunological reactivity can lead to the identification of additional antigens of M. tuberculosis useful as new vaccines and reagents for specific diagnosis of TB. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:113 / 119
页数:7
相关论文
共 70 条
  • [1] Ahmad S, 1999, SCAND J IMMUNOL, V49, P515
  • [3] ANDERSEN P, 1995, J IMMUNOL, V154, P3359
  • [4] ANDERSON RN, 1997, MONTHLY VITAL STAT R, V45, P2
  • [5] Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides
    Arend, SM
    Geluk, A
    van Meijgaarden, KE
    van Dissel, JT
    Theisen, M
    Andersen, P
    Ottenhoff, THM
    [J]. INFECTION AND IMMUNITY, 2000, 68 (06) : 3314 - 3321
  • [6] Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10
    Arend, SM
    Andersen, P
    van Meijgaarden, KE
    Skjot, RLV
    Subronto, YW
    van Dissel, JT
    Ottenhoff, THM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (05) : 1850 - 1854
  • [7] Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis
    Baldwin, SL
    D'Souza, C
    Roberts, AD
    Kelly, BP
    Frank, AA
    Lui, MA
    Ulmer, JB
    Huygen, K
    McMurray, DM
    Orme, IM
    [J]. INFECTION AND IMMUNITY, 1998, 66 (06) : 2951 - 2959
  • [8] Comparative genomics of BCG vaccines by whole-genome DNA microarray
    Behr, MA
    Wilson, MA
    Gill, WP
    Salamon, H
    Schoolnik, GK
    Rane, S
    Small, PM
    [J]. SCIENCE, 1999, 284 (5419) : 1520 - 1523
  • [9] Identification and characterization of protective T cells in hsp65 DNA-vaccinated and Mycobacterium tuberculosis-infected mice
    Bonato, VLD
    Lima, VMF
    Tascon, RE
    Lowrie, DB
    Silva, CL
    [J]. INFECTION AND IMMUNITY, 1998, 66 (01) : 169 - 175
  • [10] ESAT-6 subunit vaccination against Mycobacterium tuberculosis
    Brandt, L
    Elhay, M
    Rosenkrands, I
    Lindblad, EB
    Andersen, P
    [J]. INFECTION AND IMMUNITY, 2000, 68 (02) : 791 - 795